TBC1 domain family member 3 pseudogene 5 (TBC1D3P5)

TBC1 domain family member 3 pseudogene 5 (TBC1D3P5) is classified as a **pseudogene** and does not encode a functional protein product[3]. Unlike other members of the TBC1 domain family, which are implicated in vesicular trafficking and endocytosis (such as TBC1D3)[1][4], TBC1D3P5 itself is **not a protein-coding gene** and is not recognized as a therapeutic target, receptor, enzyme, transporter, or analogous biomacromolecule. Some genetic association data link TBC1D3P5 to gastric cancer, but there is no evidence for direct biological function, active disease mechanism, or drug interaction for this pseudogene[3]. **Notes:** - This entry can frequently be mistaken for the protein-coding gene TBC1D3 or other TBC1 family members that do have biological/therapeutic relevance, but TBC1D3P5 is itself a pseudogene and does not serve as a molecular target in the conventional sense[3]. - If structured information about the active protein TBC1D3 is required, clarify and search for TBC1D3 rather than TBC1D3P5, as TBC1D3P5 refers strictly to a non-coding pseudogene. - No canonical abbreviation beyond TBC1D3P5 was found; the gene does not participate in drug mechanisms, biomarker applications, or recognized biological pathways[3].

Other names

TBC1 domain family member 3 pseudogene 5TBC1D3P5